LOGO
LOGO

Apyx Medical Stock Strengthens On AYON Launch And U.S. Aesthetics Demand

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
apyx 13012026 lt

Apyx Medical Corp. (APYX), an energy technology company specializing in electrosurgical equipment and medical devices, is drawing investor attention following strong preliminary revenue results for the fourth quarter and full year ended December 31, 2025.

The company's Helium Plasma Technology, marketed as Renuvion and J-Plasma, offers surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19